GlaxoSmithKline to go for smart tech
Author: Ben Hirschler
Major drug makers are grappling with the effects of technology as digital apps offer patients new ways to monitor their health. GlaxoSmithKline has appointed former Wal-Mart Stores executive Karenann Terrell to the new senior position of chief digital and technology officer as the drug maker begins to move to smart tech systems.
The move reflects a desire by CEO Emma Walmsley, who took over in April, to apply digital platforms in everything from clinical trials to customer interactions. It comes a day before GlaxoSmithKline reports quarterly results.
Major drug makers are grappling with the effects of technology on their businesses, as digital apps offer patients new ways to monitor their health and online communications with prescribers and consumers become routine.
For Walmsley, Terrell is another important appointment following the hiring of former AstraZeneca star executive Luke Miels, who will also join in September.
Both will be important lieutenants as the GlaxoSmithKline CEO strives to improve the competitive profile of the company’s operations, from prescription drugs to toothpaste.
Terrell, who left Wal-Mart as chief information officer in February, will join GlaxoSmithKline on September 4 as member of the senior corporate executive team, it said.
Prior to working at Wal-Mart, Terrell was at US healthcare group Baxter International and before that at Daimler Chrysler.
“As a member of the executive team, Karenann will have the scope to think radically about how we can exploit the latest opportunities and ultimately improve our business performance,” said Walmsley in a statement.
Source: Business Day